Serum levels of the neurofilament light chain (NfL) may be a useful biomarker of neuroaxonal injury in people with traumatic brain injuries (TBI), new research suggests. Already validated in neurodegenerative disorders such as Alzheimer’s disease and MS, NfL was recently measured in a cohort of Swedish ice-hockey players and in a US clinic-based TBI cohort. ...
New potential blood biomarker for brain injury
By Mardi Chapman
17 Jul 2020